#Induced Pluripotent Market share

[industryforecastnews]

Induced Pluripotent Stem Cells Production Market To Reach USD 2.76 Billion By 2030

Induced Pluripotent Stem Cells Production Market Growth & Trends

The global induced pluripotent stem cells production market size is expected to reach USD 2.76 billion by 2030, registering a CAGR of 9.44% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increase in demand for induced pluripotent stem cells (iPSCs) in comparison to Embryonic Stem Cells (ESCs) has offered a significant drive to the market. Advantages such as no stem cell-related ethical issues, personalized treatment, and flexibility during cell-based research have created a favorable scenario for market growth. In addition, the prevalence of chronic disorders is also driving the growth of the induced pluripotent stem cells production market, as conditions like heart disease, stroke, diabetes, and many more can be treated by utilizing iPSCs-mediated therapy. For example, according to the International Diabetes Federation (IDF), 537 million people are already living with diabetes in 2021.

The rising research activities during COVID-19 pandemic have positively impacted the market. The pandemic fueled research in many fields as the SARS CoV-2 infection resulted in many diseases in the patients. For instance, in April 2021, researchers from USA stated that up to 25% of COVID-19 patients suffered cardiac dysfunction. Through their research article, they demonstrated the pathogenesis via exposure of iPSCs-derived cardiac cells to SARS CoV-2, and similar alterations were confirmed from human autopsy specimens of the patients. Such insights allow the use of induced pluripotent stem cells (iPSCs) as drug or therapy development platforms and their utilization in the management of the long-term effects of COVID-19.

Induced pluripotent stem cells are cells that are derived from adult somatic cells and then further reprogrammed to obtain the pluripotency as that of ESCs. These iPSCs are proving to be an ethically uncomplicated alternative for research that involves ESCs. The derivation of the ESCs is associated with the destruction of an embryo at the blastocyte stage, which has led to a maximum number of ethical debates. However, induced pluripotent stem cells have solved the ethical issue over the destruction of human embryos in research by involving only the genetic reprogramming of somatic cells. This has propelled the market growth and resulted in numerous applications including drug discovery, disease modeling, toxicology testing, and many others. For instance, in August 2021, Fate Therapeutics announced the treatment of the first patient with FT819 during clinical trials. FT819 is an engineered CAR-T cell therapy that is derived from iPSCs. Also, the rising focus of the research community on exploring applications of induced pluripotent stem cells in regenerative medicine due to their unique characteristics such as differential potential, self-renewable, immunomodulatory properties, and others; is set to drive the market expansion.

Request a free sample copy or view the report summary: https://www.grandviewresearch.com/industry-analysis/induced-pluripotent-stem-cells-production-market-report

Induced Pluripotent Stem Cells Production Market Report Highlights

By process, the manual iPSC production process segment dominated the market and accounted for the largest revenue share in 2023.

By workflow, the cell culture segment dominated the market with the largest revenue share of 37.34% in 2023. Cell culture workflow is inclusive of revenues generated from iPSC harvest products, expansion products, and differentiation products; thus contributing to the market relevance of this segment.

By product, the consumables and kits segment dominated the market and accounted for the largest revenue share of 40.32% in 2023. The never-ceasing research and development activities in the iPSCs space are driving the demand for various consumables & kits.

By application, drug development & discovery segment dominated the market with the largest revenue share of 43.33% in 2023.

By end-user, the biotechnology and pharmaceutical companies segment dominated the market with the largest revenue share of 59.35% in 2023. The availability and adoption of various kits, consumables, and instruments along with iPSCs products are driving the revenue generation in this segment.

North America dominated the market and accounted for the largest revenue share of 40.98% in 2023. The growing incidence of chronic diseases in this region, developed healthcare infrastructure, funds from private & government initiatives, and strategic business models are driving the revenue generation in the marketspace. 

Induced Pluripotent Stem Cells Production Market Segmentation

Grand View Research has segmented the global induced pluripotent stem cells production market based on process, workflow, product, application, end-use, and region:

Induced Pluripotent Stem Cells Production Process Outlook (Revenue, USD Million, 2018 - 2030)

Manual iPSC Production Process

Automated iPSC Production Process

Induced Pluripotent Stem Cells Production Workflow Outlook (Revenue, USD Million, 2018 - 2030)

Reprogramming

Cell Culture

Cell Characterization/Analysis

Engineering

Others

Induced Pluripotent Stem Cells Production Product Outlook (Revenue, USD Million, 2018 - 2030)

Instruments/ Devices

Automated Platforms

Consumables & Kits

Media

Kits

Others

Services

Induced Pluripotent Stem Cells Production Application Outlook (Revenue, USD Million, 2018 - 2030)

Drug Development & Discovery

Regenerative Medicine

Toxicology Studies

Others

Induced Pluripotent Stem Cells Production End-use Outlook (Revenue, USD Million, 2018 - 2030)

Research & Academic Institutes

Biotechnology & Pharmaceutical Companies

Hospitals & Clinics

Induced Pluripotent Stem Cells Production Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Mexico

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

Latin America

Brazil

Argentina

Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Kuwait

List of Key Players in Induced Pluripotent Stem Cells Production Market

Lonza

Axol Bioscience Ltd.

Evotec

Hitachi, Ltd.

REPROCELL Inc.

Merck KGaA

REPROCELLS, Inc.

Fate Therapeutics

Thermo Fisher Scientific, Inc.

StemCellsFactory III

Applied StemCells, Inc.

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/induced-pluripotent-stem-cells-production-market-report

[digimarketresearch]

Induced Pluripotent Stem Cells Market Size, Share, Trends, Global Demand, Growth and Opportunity Analysis

"Induced Pluripotent Stem Cells (iPSCs) Market survey report analyses the general market conditions such as product price, profit, capacity, production, supply, demand, and market growth rate which supports businesses on deciding upon several strategies. Furthermore, big sample sizes have been utilized for the data collection in this business report which suits the necessities of small, medium as well as large size of businesses. The report explains the moves of top market players and brands that range from developments, products launches, acquisitions, mergers, joint ventures, trending innovation and business policies.

The large scale Induced Pluripotent Stem Cells (iPSCs) Market report is prepared by taking into account the market type, organization volume, accessibility on-premises, end-users’ organization type, and availability at global level in areas such as North America, South America, Europe, Asia-Pacific, Middle East and Africa. Extremely talented pool has invested a lot of time for doing market research analysis and to generate this market report. Induced Pluripotent Stem Cells (iPSCs) Market report is sure to help businesses for the long lasting accomplishments in terms of better decision making, revenue generation, prioritizing market goals and profitable business.

Access Full 350 Pages PDF Report @

The global induced pluripotent stem cells (iPSCs) market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.9% in the forecast period of 2022 to 2029 and is expected to reach USD 2,081.08 million by 2029. Increasing research activities over stem cell therapies act as driver for the induced pluripotent stem cells (iPSCs) market growth.

Key Coverage in the Induced Pluripotent Stem Cells (iPSCs) Market Report:

Detailed analysis of Induced Pluripotent Stem Cells (iPSCs) Market by a thorough assessment of the technology, product type, application, and other key segments of the report

Qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period

Investigative study of the market dynamics including drivers, opportunities, restraints, and limitations that can influence the market growth

Comprehensive analysis of the regions of the Induced Pluripotent Stem Cells (iPSCs) industry and their futuristic growth outlook

Competitive landscape benchmarking with key coverage of company profiles, product portfolio, and business expansion strategies

Table of Content:

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Global Induced Pluripotent Stem Cells (iPSCs) Market Landscape

Part 04: Global Induced Pluripotent Stem Cells (iPSCs) Market Sizing

Part 05: Global Induced Pluripotent Stem Cells (iPSCs) Market Segmentation by Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

The major companies which are dealing in the induced pluripotent stem cells (iPSCs) are Thermo Fisher Scientific Inc., FUJIFILM Corporation, LumaCyte,  Horizon Discovery Ltd., Hopstem Biotechnology LLC., Takara Bio Inc., Cell Applications, Inc., Citius Pharmaceuticals, Inc., Lonza., Evotec SE., Fate Therapeutics, Universal Cells Inc. (An Astellas Company), Axol Bioscience Ltd., R & D Systems, Inc., Charles River Laboratories International, Inc., Corning Incorporated, REPROCELL Inc., Applied StemCell., Merck KGaA, GeneCopoeia, Inc. and among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse Trending Reports:

Dupuytrens Disease Market

Mitogen Activated Protein Kinase Mapk Inhibitors Therapeutics Market

Neonatal Seizures Drugs Market

Chikungunya Treatment Market

Sickle Cell Disease Treatment Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: corporatesales@databridgemarketresearch.com"

[aimarketresearch]

Induced Pluripotent Stem Cells Market Size, Share, Trends, Demand, Future Growth, Challenges and Competitive Analysis

Induced Pluripotent Stem Cells (iPSCs) Market survey report analyses the general market conditions such as product price, profit, capacity, production, supply, demand, and market growth rate which supports businesses on deciding upon several strategies. Furthermore, big sample sizes have been utilized for the data collection in this business report which suits the necessities of small, medium as well as large size of businesses. The report explains the moves of top market players and brands that range from developments, products launches, acquisitions, mergers, joint ventures, trending innovation and business policies.

The large scale Induced Pluripotent Stem Cells (iPSCs) Market report is prepared by taking into account the market type, organization volume, accessibility on-premises, end-users’ organization type, and availability at global level in areas such as North America, South America, Europe, Asia-Pacific, Middle East and Africa. Extremely talented pool has invested a lot of time for doing market research analysis and to generate this market report. Induced Pluripotent Stem Cells (iPSCs) Market report is sure to help businesses for the long lasting accomplishments in terms of better decision making, revenue generation, prioritizing market goals and profitable business.

Access Full 350 Pages PDF Report @

The global induced pluripotent stem cells (iPSCs) market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.9% in the forecast period of 2022 to 2029 and is expected to reach USD 2,081.08 million by 2029. Increasing research activities over stem cell therapies act as driver for the induced pluripotent stem cells (iPSCs) market growth.

Key Coverage in the Induced Pluripotent Stem Cells (iPSCs) Market Report:

Detailed analysis of Induced Pluripotent Stem Cells (iPSCs) Market by a thorough assessment of the technology, product type, application, and other key segments of the report

Qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period

Investigative study of the market dynamics including drivers, opportunities, restraints, and limitations that can influence the market growth

Comprehensive analysis of the regions of the Induced Pluripotent Stem Cells (iPSCs) industry and their futuristic growth outlook

Competitive landscape benchmarking with key coverage of company profiles, product portfolio, and business expansion strategies

Table of Content:

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Global Induced Pluripotent Stem Cells (iPSCs) Market Landscape

Part 04: Global Induced Pluripotent Stem Cells (iPSCs) Market Sizing

Part 05: Global Induced Pluripotent Stem Cells (iPSCs) Market Segmentation by Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

The major companies which are dealing in the induced pluripotent stem cells (iPSCs) are Thermo Fisher Scientific Inc., FUJIFILM Corporation, LumaCyte,  Horizon Discovery Ltd., Hopstem Biotechnology LLC., Takara Bio Inc., Cell Applications, Inc., Citius Pharmaceuticals, Inc., Lonza., Evotec SE., Fate Therapeutics, Universal Cells Inc. (An Astellas Company), Axol Bioscience Ltd., R & D Systems, Inc., Charles River Laboratories International, Inc., Corning Incorporated, REPROCELL Inc., Applied StemCell., Merck KGaA, GeneCopoeia, Inc. and among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse Trending Reports:

Digital Mobile X Ray Devices Market

Point Of Care Poc Urinalysis Market

Viral Clearance Services Market

Preparative And Process Chromatography Market

Next Generation Dna Sequencing Ngs Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: corporatesales@databridgemarketresearch.com

[trendtrackershq]

Regenerative Medicine Market: Asia-Pacific Emerges as a Dominant Player

Introduction:

The regenerative medicine market is experiencing a significant transformation, driven by advances in biotechnology, stem cell research, and tissue engineering. Among the various regions contributing to this rapid evolution, the Asia-Pacific (APAC) region stands out as a dominant player poised for the most rapid growth in the coming years. This article delves into the factors contributing to APAC's leadership in the regenerative medicine market, highlighting key acquisitions, technological advancements, and strategic initiatives that underscore its burgeoning influence.

Download Free Sample: https://www.nextmsc.com/regenerative-medicine-market/request-sample

The Surge of Regenerative Medicine in Asia-Pacific

Regenerative medicine, which focuses on repairing or replacing damaged tissues and organs through cellular therapy, tissue engineering, and gene editing, is a revolutionary field with immense potential. The APAC region is uniquely positioned to capitalize on this potential due to a combination of demographic trends, supportive governmental policies, and strategic corporate activities.

Demographic and Economic Factors

One of the primary drivers of growth in the regenerative medicine market in APAC is its large and aging population. Countries like Japan, China, and South Korea face significant challenges related to aging demographics, with a rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and neurodegenerative disorders. This demographic shift increases the demand for innovative medical solutions that regenerative medicine promises.

Moreover, the economic expansion across APAC countries has led to increased healthcare spending. Governments and private sectors are investing heavily in healthcare infrastructure and research and development (R&D), fostering an environment conducive to advancements in regenerative medicine.

Strategic Acquisitions and Collaborations

Strategic acquisitions and collaborations have been pivotal in propelling the APAC region to the forefront of the regenerative medicine market. A notable example is Canon's acquisition of Kyoto Seisakusho's cell culture operations. This acquisition, which includes patented technologies, signifies Canon's strategic entry into the regenerative medicine space. By integrating Kyoto Seisakusho's expertise in cell culture with Canon's technological capabilities, the company aims to accelerate the development and commercialization of regenerative therapies.

Such acquisitions are not isolated incidents but part of a broader trend where major corporations and startups alike are seeking synergistic partnerships. These collaborations are instrumental in pooling resources, sharing knowledge, and overcoming technical and regulatory challenges, thereby fast-tracking the development of regenerative therapies.

Technological Advancements

Technological innovation is at the heart of the regenerative medicine market's growth in APAC. The region boasts numerous cutting-edge research institutions and biotechnology companies that are pioneering advances in stem cell research, gene editing, and tissue engineering.

For instance, Japan has been a leader in induced pluripotent stem cell (iPSC) technology, with Nobel laureate Shinya Yamanaka's groundbreaking work laying the foundation for numerous therapeutic applications. Similarly, China has made significant strides in gene editing technologies, particularly CRISPR, which holds promise for treating a wide range of genetic disorders.

The integration of artificial intelligence (AI) and big data analytics into regenerative medicine research is another critical factor. AI-driven platforms are being used to predict cellular behavior, optimize tissue engineering processes, and accelerate drug discovery, thereby enhancing the efficiency and effectiveness of regenerative therapies.

Regulatory Support and Policy Initiatives

Supportive regulatory frameworks and proactive government policies play a crucial role in the development of the regenerative medicine market in APAC. Countries in the region are increasingly adopting regulations that facilitate the clinical translation of regenerative therapies.

Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has been at the forefront of this regulatory evolution, introducing the Sakigake Designation system, which accelerates the review and approval process for innovative therapies, including regenerative medicines. This system not only shortens the time-to-market for new treatments but also ensures rigorous safety and efficacy standards.

China has also reformed its regulatory environment, with the National Medical Products Administration (NMPA) implementing policies to expedite the approval of cell and gene therapies. These regulatory advancements reduce barriers to market entry and encourage both domestic and international companies to invest in the region.

Inquire Before Buying: https://www.nextmsc.com/regenerative-medicine-market/inquire-before-buying

Market Dynamics and Competitive Landscape

The competitive landscape of the regenerative medicine market in APAC is characterized by a mix of established pharmaceutical giants, emerging biotech firms, and academic institutions. Companies are increasingly focusing on developing proprietary technologies and expanding their product pipelines to gain a competitive edge.

For example, Fujifilm Holdings Corporation, originally known for its photographic products, has diversified into regenerative medicine by acquiring Cellular Dynamics International and Japan Tissue Engineering Co., Ltd. These acquisitions have enabled Fujifilm to leverage its expertise in high-quality production and quality control to advance regenerative therapies.

Similarly, South Korea's Medipost is a leader in stem cell therapy, with its flagship product, Cartistem, approved for treating knee cartilage defects. The company's robust R&D efforts and clinical trial successes underscore the growing prominence of APAC companies in the global regenerative medicine market.

Future Outlook

The future of the regenerative medicine market in APAC looks promising, with continued growth anticipated over the next decade. Factors such as increasing investment in R&D, technological innovation, favorable regulatory environments, and strategic partnerships are expected to sustain the region's momentum.

Furthermore, as personalized medicine gains traction, regenerative therapies tailored to individual genetic profiles will become more prevalent, driving demand and opening new market opportunities. The convergence of regenerative medicine with other emerging fields, such as nanotechnology and 3D bioprinting, will also spur innovation and expand therapeutic possibilities.

Conclusion

The Asia-Pacific region is emerging as a powerhouse in the regenerative medicine market, driven by a confluence of demographic trends, economic growth, technological advancements, strategic acquisitions, and supportive regulatory frameworks. As countries in the region continue to prioritize healthcare innovation and investment, APAC is well-positioned to lead the global market in regenerative medicine, offering new hope for patients with previously untreatable conditions and setting the stage for the next frontier in medical science.

[nidarsanafwr]

https://carbonfacesocial.org/blogs/58273/Induced-Pluripotent-Stem-Cells-Market-Share-Overview-Competitive-Analysis-and

Induced Pluripotent Stem Cells Market Share, Overview, Competitive Analysis and Forecast 2031

[digitrenndsamr]

Strategic Investments Propel Industrial Gases Market Growth Through 2031

Industrial gases mainly consist of carbon dioxide, hydrogen, nitrogen, oxygen, and noble gases (helium, neon, argon, krypton, xenon and radon). The atmospheric gases like oxygen, nitrogen, and argon are captured by reducing the temperature of the air until the respective components get liquefied and separated. New developments are taking place in healthcare with increasing emphasis on a healthier and generally better quality of life. In addition to oxygen, nitrous oxide, nitric oxides, and other industrial gases like hydrogen, helium, and xenon are all being prepared for use in pharmaceutical-based products. Treatments and drug developments using induced pluripotent stem cells (IPS) are bringing a new added value to the industry through the application of systems, using gases such as carbon dioxide and liquid nitrogen, which is indispensable for the cultivation and preservation of cells and tissues driving demand for high-grade industrial gases. The industrial gases market size was valued at $93.8 billion in 2021, and the industrial gases industry is estimated to reach $162.8 billion by 2031, growing at a CAGR of 5.7% from 2022 to 2031.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐑𝐞𝐬𝐞𝐚����𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 & 𝐓𝐎𝐂: https://www.alliedmarketresearch.com/request-sample/6169

The coronavirus pandemic has weakened all the businesses in the industrial gases market; manufacturers are creating potential opportunities, owing to increasing applications of industrial gases in various end-use industries across the globe. Increasing demand for oxygen, nitrogen, carbon dioxide, hydrogen, and argon in different end-use industries, such as consumer electronics, semiconductors, food & beverages, healthcare, mining, and others is generating revenue streams for manufacturers in the industrial gases market. Countries such as India and China are expected to witness rapid growth due to industrialization and urbanization.

The increase in demand for power and increasing consumption of energy in the past decade have led to the development of new technologies, such as nuclear fusion, hydrogen fuel cells, and green ammonia, which have a positive impact on the demand for industrial gases.

The rapid development towards highly stable and small-scale nuclear fission reactors is expected to drive the demand for noble gases, which are used in nuclear reactors. The huge investment of major countries across the globe and vision to ignite nuclear fusion technology by 2050 and the application of noble gas as a fuel and as a raw material to manufacture laser ignition systems drive the growth of the market.

𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐰𝐢𝐭𝐡 𝐲𝐨𝐮'𝐫𝐞 𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭𝐬: https://www.alliedmarketresearch.com/request-for-customization/6169

Furthermore, an increase in the investment of developing and developed countries in hydrogen fuel cell technologies, and engines to harvest the energy are expected to have a positive impact on the market. An increase in demand for power in the future and rapid innovation and breakthroughs in the core technologies for nuclear fusion reactors will provide lucrative opportunities for the industrial gas market growth.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:

The Industrial Gases industry's key market players adopt various strategies such as product launches, product development, collaboration, partnership, and agreements to influence the market. It includes details about the key players in the market's strengths, product portfolio, market size and share analysis, operational results, and market positioning.

𝐒𝐨𝐦𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐚𝐣𝐨𝐫 𝐤𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐢𝐚𝐥 𝐆𝐚𝐬𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞,

Linde Plc Southern Gas Ltd. Air Products & Chemicals Messer Group Gulf Cryo National Gases Ltd. MVS Engineering Pvt. Ltd. International Industrial Gases Limited Goyal MG Gases Pvt. Ltd. Praxair Technology, Inc. Universal Industrial Gases, Inc. Taiyo Nippon Sanso BASF SE AIR LIQUIDE S.A. Ellenbarrie Industrial Gases

The industrial gases market forecast is segmented based on type, end-user, and region. Based on type, the market is segmented into oxygen, carbon dioxide, nitrogen, hydrogen, noble gas, and others. In addition, based on end-use, the industrial gases market is segmented into healthcare, electronics, aerospace, construction, energy & power, and others.

Region-wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA. Presently, Asia-Pacific accounts for the largest industrial gas market share, followed by North America and Europe.

𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐛𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠: https://www.alliedmarketresearch.com/purchase-enquiry/6169

𝐊𝐞𝐲 𝐟𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐬𝐭𝐮𝐝𝐲:

1. Asia-Pacific held a dominant position in 2021 and is expected to maintain its lead during the forecast period.

2. As per industrial gases market analysis, South Korea is expected to exhibit a CAGR of 6.5% during 2022-2031.

3. Japan is expected to exhibit a CAGR of 5.3% during 2022-2031.

4. By type, the oxygen segment accounted for the market share of 35.2% in 2021.

5. By end-use, the construction segment is expected to contribute a market share of 27.7% by 2031.

𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐄𝐧𝐞𝐫𝐠𝐲 𝐚𝐧𝐝 𝐏𝐨𝐰𝐞𝐫 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲:

𝟏. 𝐎𝐫𝐠𝐚𝐧𝐢𝐜 𝐁𝐢𝐨𝐠𝐚𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 - https://www.globenewswire.com/news-release/2022/11/21/2560018/0/en/Global-Organic-Biogas-Market-to-Reach-19-7-Billion-by-2031-Allied-Market-Research.html

𝟐. 𝐏𝐨𝐰𝐞𝐫-𝐭𝐨-𝐠𝐚𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 - https://www.prnewswire.com/news-releases/power-to-gas-market-to-reach-84-4-mn-globally-by-2031-at-10-8-cagr-allied-market-research-301597797.html

𝟑. 𝐒𝐡𝐚𝐥𝐞 𝐆𝐚𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 - https://www.globenewswire.com/news-release/2022/06/06/2456719/0/en/Global-Shale-Gas-Market-Is-Expected-to-Reach-130-3-Billion-by-2030-Says-AMR.html

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Allied Market Research is a top provider of market intelligence that offers reports from leading technology publishers. Our in-depth market assessments in our research reports take into account significant technological advancements in the sector. In addition to other areas of expertise, AMR focuses on the analysis of high-tech systems and advanced production systems. We have a team of experts who compile thorough research reports and actively advise leading businesses to enhance their current procedures. Our experts have a wealth of knowledge on the topics they cover. Also, they use a variety of tools and techniques when gathering and analyzing data, including patented data sources.

[severepeanutperfection]

Induced Pluripotent Stem Cells Production Market Latest Advancements and Business Opportunities 2032

The Induced Pluripotent Stem Cells (iPSCs) Production Market is experiencing significant growth and revolutionizing the field of regenerative medicine. iPSCs are derived from adult cells that have been reprogrammed to exhibit characteristics similar to embryonic stem cells. These cells have the unique ability to differentiate into various cell types in the human body, making them a promising tool for disease modeling, drug discovery, and cell-based therapies.

One of the key drivers of the iPSCs Production Market is the growing prevalence of chronic diseases and the increasing demand for personalized medicine. iPSCs offer the potential to generate patient-specific cells for disease modeling and drug testing, enabling researchers to develop targeted therapies tailored to individual patients. This personalized approach has the potential to revolutionize the treatment of conditions such as cardiovascular diseases, neurodegenerative disorders, and genetic disorders.

Moreover, advancements in reprogramming techniques and the optimization of iPSC production protocols have significantly improved the efficiency and scalability of iPSC generation. The development of non-integrating reprogramming methods and the use of small molecules have minimized genomic instability and increased the safety and reliability of iPSC production. These technological advancements have contributed to the market growth by making iPSCs more accessible and practical for research and clinical applications.

Additionally, collaborations between academia, industry, and regulatory bodies have played a crucial role in driving the iPSCs Production Market. These partnerships have facilitated knowledge sharing, standardization of protocols, and the development of guidelines for iPSC production and characterization. The establishment of regulatory frameworks for the clinical translation of iPSC-based therapies has further fueled the market growth, ensuring the safety and efficacy of these advanced treatment approaches.

For More Info@ https://www.persistencemarketresearch.com/market-research/induced-pluripotent-stem-cells-production-market.asp

In conclusion, the iPSCs Production Market is poised for significant expansion as it offers a transformative platform for disease modeling, drug discovery, and cell-based therapies. With the increasing prevalence of chronic diseases and the need for personalized medicine, iPSCs have emerged as a powerful tool in regenerative medicine. Continued advancements in reprogramming techniques, scalability, and regulatory support will further propel the market, leading to the development of innovative therapies and improved patient outcomes in the future.

[digimarketresearch]

Neonatal Seizures Drugs Market Size, Share, Trends, Global Demand, Growth and Opportunity Analysis

"Data Bridge Market research has recently issued comprehensive industry research on Global Neonatal Seizures Drugs Market which includes growth analysis, regional marketing, challenges, opportunities, and drivers analysed in the report. The market insights gained through this Neonatal Seizures Drugs market research analysis report facilitates more defined understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently.

An analysis of competitors is conducted very well in the reliable Neonatal Seizures Drugs Market report which covers vital market aspects about the key players. Moreover, the report gives out market potential for many regions across the globe based on the growth rate, macroeconomic parameters, consumer buying patterns, their preferences for particular product and market demand and supply scenarios. It gives significant information and data pertaining to their insights in terms of finances, product portfolios, investment plans, and marketing and business strategies. Detailed market analysis has been performed here with the inputs from industry experts.

Access Full 350 Pages PDF Report @

Data Bridge Market Research analyses that the neonatal seizures drugs? market was valued at USD 222.5 million in 2021 and is expected to reach USD 290.73 million by 2029, registering a CAGR of 3.40% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Highlights of TOC:

Chapter 1: Market overview

Chapter 2: Global Neonatal Seizures Drugs Market

Chapter 3: Regional analysis of the Global Neonatal Seizures Drugs Market industry

Chapter 4: Neonatal Seizures Drugs Market segmentation based on types and applications

Chapter 5: Revenue analysis based on types and applications

Chapter 6: Market share

Chapter 7: Competitive Landscape

Chapter 8: Drivers, Restraints, Challenges, and Opportunities

Chapter 9: Gross Margin and Price Analysis

Key Questions Answered with this Study

1) What makes Neonatal Seizures Drugs Market feasible for long term investment?

2) Know value chain areas where players can create value?

3) Teritorry that may see steep rise in CAGR & Y-O-Y growth?

4) What geographic region would have better demand for product/services?

5) What opportunity emerging territory would offer to established and new entrants in Neonatal Seizures Drugs Market?

6) Risk side analysis connected with service providers?

7) How influencing factors driving the demand of Neonatal Seizures Drugsin next few years?

8) What is the impact analysis of various factors in the Global Neonatal Seizures Drugs Market growth?

9) What strategies of big players help them acquire share in mature market?

10) How Technology and Customer-Centric Innovation is bringing big Change in Neonatal Seizures Drugs Market?

Some of the major players operating in the neonatal seizures drugs? market are:

Merck KGaA (Germany)

Eisai Co., Ltd. (Japan)

AstraZeneca (UK)

Sanofi (France)

Novartis AG (Switzerland)

Abbott (US)

F. Hoffmann-La Roche Ltd. (Switzerland)

Teva Pharmaceutical Industries Ltd. (Ireland)

Pfizer Inc. (US)

GlaxoSmithKline plc (UK)

WOCKHARDT (Mumbai)

Novo Nordisk A/S (Denmark)

Glenmark Pharmaceuticals Limited (India)

Cipla Inc. (US)

Bausch Health Companies Inc. (Canada)

Otsuka America Pharmaceutical, Inc. (US)

Johnson & Johnson Private Limited (US)

Takeda Pharmaceutical Company Limited (Japan)

Sumitomo Corporation (Japan)

Biocon (India)

Browse Trending Reports:

Medical Tuning Fork Market

North America Cbct Dental Imaging Market

Myopia Treatment Market

Induced Pluripotent Stem Cells Market

Pneumococcal Vaccine Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: corporatesales@databridgemarketresearch.com"

[pranalipawarshinde]

Stem Cells Market Growth, Trends, and Forecast, 2021-2028

Stem Cells Market: Introduction

According to the report, the global stem cells market was valued at US$ 11.73 Bn in 2020 and is projected to expand at a CAGR of 10.4% from 2021 to 2028. Stem cells are defined as specialized cells of the human body that can develop into various different kinds of cells. Stem cells can form muscle cells, brain cells and all other cells in the body. Stem cells are used to treat various illnesses in the body.

Report Overview: https://www.transparencymarketresearch.com/stem-cells-market.html

North America was the largest market for stem cells in 2020. The region dominated the global market due to substantial investments in the field, impressive economic growth, increase in incidence of target chronic diseases, and technological progress. Moreover, technological advancements, increase in access to healthcare services, and entry of new manufacturers are the other factors likely to fuel the growth of the market in North America during the forecast period.

Asia Pacific is projected to be a highly lucrative market for stem cells during the forecast period. The market in the region is anticipated to expand at a high CAGR during the forecast period. High per capita income has increased the consumption of diagnostic and therapy products in the region. Rapid expansion of the market in the region can be attributed to numerous government initiatives undertaken to improve the health care infrastructure. The market in Asia Pacific is estimated to expand rapidly compared to other regions due to shift in base of pharmaceutical companies and clinical research industries from developed to developing regions such as China and India. Moreover, changing lifestyles and increase in urbanization in these countries have led to a gradual escalation in the incidence of lifestyle-related diseases such as cancer, diabetes, and heart diseases.

Technological Advancements to Drive Market

Several companies are developing new approaches to culturing or utilizing stem cells for various applications. Stem cell technology is a rapidly developing field that combines the efforts of cell biologists, geneticists, and clinicians, and offers hope of effective treatment for various malignant and non-malignant diseases. The stem cell technology is progressing as a result of multidisciplinary effort, and advances in this technology have stimulated a rapid growth in the understanding of embryonic and postnatal neural development.

Get Sample Copy of the Report@

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=132

Adult Stem Cells Segment to Dominate Global Market

In terms of product type, the global stem cells market has been classified into adult stem cells, human embryonic stem cells, and induced pluripotent stem cells. The adult stem cells segment accounted for leading share of the global market in 2020. The capability of adult stem cells to generate a large number of specialized cells lowers the risk of rejection and enables repair of damaged tissues.

Autologous Segment to Lead Market

Based on source, the global stem cells market has been bifurcated into autologous and allogenic. The autologous segment accounted for leading share of the global market in 2020. Autologous stem cells are used from one’s own body to replace damaged bone marrow and hence it is safer and is commonly being practiced.

Regenerative Medicines to be Highly Lucrative

In terms of application, the global stem cells market has been categorized into regenerative medicines (neurology, oncology, cardiology, and others) and drug discovery & development. The regenerative medicines segment accounted for major share of the global market in 2020, as regenerative medicine is a stem cell therapy and the medicines are made using stem cells in order to repair an injured tissue. Increase in the number of cardiac diseases and other health conditions drive the segment.

Request Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=132

Therapeutics Companies Emerge as Major End-users

Based on end-user, the global stem cells market has been divided into therapeutics companies, cell & tissue banks, tools & reagents companies, and service companies. The therapeutics companies segment dominated the global stem cells market in 2020. The segment is driven by increase in usage of stem cells to treat various illnesses in the body. Therapeutic companies are increasing the utilization of stem cells for providing various therapies. However, the cell & tissue banks segment is projected to expand at a high CAGR during the forecast period. Increase in number of banks that carry out research on stem cells required for tissue & cell growth and elaborative use of stem cells to grow various cells & tissues can be attributed to the growth of the segment.

Regional Analysis

In terms of region, the global stem cells market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global stem cells market in 2020, followed by Europe. Emerging markets in Asia Pacific hold immense growth potential due to increase in income levels in emerging markets such as India and China leading to a rise in healthcare spending.

Competition Landscape

The global stem cells market is fragmented in terms of number of players. Key players in the global market include STEMCELL Technologies, Inc., Astellas Pharma, Inc., Cellular Engineering Technologies, Inc., BioTime, Inc., Takara Bio, Inc., U.S. Stem Cell, Inc., BrainStorm Cell Therapeutics, Inc., Cytori Therapeutics, Inc., Osiris Therapeutics, Inc., and Caladrius Biosciences, Inc.

Stem Cells Market, by Application

·         Regenerative Medicines

o    Neurology

o    Oncology

o    Cardiology

o    Others

·         Drug Discovery & Development

Ask References: https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=132

Stem Cells Market, by End-user

·         Therapeutics Companies

·         Cell & Tissue Banks

·         Tools & Reagents Companies

·         Service Companies

 About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

 Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

 Contact

Nikhil Sawlani Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: 1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com Blog:  https://tmrblog.com Email: sales@transparencymarketresearch.com

[thingsgreys]

Columbia stem cell treatment cost

Although, certain restrictions were removed in 2009. There have never been any federal laws in the United States that have banned stem cell research, but there have been restrictions on funding and use. And, with 33 of the 50 people listed in ‘ Most Influential People on Stem Cells Today ’ being from North America, it’s clear that the United States and Canada are very involved in research for the stem cell therapeutics market. The rest of Europe is (for the most part) quite permissive, with Belgium, Sweden and the UK having the least restrictive policies and Austria, Ireland, Luxembourg and Poland having no legislation about hESCs at all.Īs the global stem cell market grows, with an expected value of $270.5 Billion by 2025, North America’s market share also grows and is expected to be worth $167.33 by 2025. Croatia, Lithuania, and Slovakia also have very restrictive policies. Nonetheless, Italy and Germany both have some of Europe’s most restrictive legislation regarding stem cell research. After scientists successfully cloned a sheep in Scotland back in 1996, Britain has been Europe’s leader. Spain, Italy, Germany and – of course – the United Kingdom are all contributing to stem cell research in a big way. As a result, research on in-vitro cultures of intact human embryos beyond 14 days of fertilisation and research on xenogenic cells, xenogenic-human hybrids, modified human embryos, and germ-line stem cells have been banned.Ĭountries like Japan and Singapore are both seen as leaders in stem cell therapies and, though they might not have the outputs of China – are internationally recognized for the work they continue to do in the field. If you look at international publication trends, between 20, China’s stem cell research output jumped from 176 articles to 677.Įlsewhere in Asia, the Indiana Council of Medical Research (ICMR) recently issued a revised draft of the National Guidelines for Stem Cell Research after noting the need for rigorous clinical trials and regulatory processes in developing safe and effective stem cell therapies. In fact, stem cell research has become a focal point for the government’s plan for developing the life sciences and biomedical sectors and there’s been an extraordinary amount of money put forth to equip laborites with the latest technology. Stem cell research in the second largest country in Asia – China – has progressed significantly since the official policy on stem cells was announced in 2015. Here, attendees discussed initiatives for developing stem cell therapies for diseases like cancer, diabetes and other non-communicable diseases that have overtaken HIV as the major cause of death in Africa Nonetheless, scientists and researchers are still working together at workshops like the one held in Stellenbosch, South Africa. Without concrete rules and government support, the growth of stem cell research is stifled, and Africa as a whole isn’t able to contribute as much to the field. In most other African Arab countries, there isn’t clear legislation that controls stem cell research, and governing bodies rely on established religious and ethical beliefs. But Tunisia is the exception, not the rule. In Egypt, experimental stem cell research (including cloning) is generally accepted whereas, in Tunisia, it’s prohibited, along with research of embryonic stem cells. But, the legislation isn’t strictly implemented and is often completely overlooked, especially for medical scientists involved in stem cell tourism. In South Africa, regulatory legislation has existed since 2013 and is mostly concerned with the use of embryo derived stem cells, induced pluripotent stem cells and adult stem cells. But, given legislative issues and religious beliefs, this isn’t surprising. Here’s a look at stem cell research around the world.Īs a continent, Africa is lagging behind others in terms of research and clinical trials related to stem cells with 80% of Mesenchymal stem cell clinical trials occurring in Asia, Europe and North America and just 2.5% occurring in Africa. But, it’s important to recognise that there isn’t one set of laws that govern the globe and some countries are extremely limited by the laws and policies that are in place. In Canada, neural stem cells are being used to restore motor impairments caused by cerebral palsy. In China, stem cells from baby teeth are being used to regrow damaged dental tissue. The field is growing quickly as clinical trials prove that stem cell therapies have the potential to treat or reduce symptoms of diseases, conditions and disabilities that have, up until this point, been untreatable. Around the world, different countries – and entire continents – are working separately but collectively to develop innovative and life-changing treatments through stem cell research.

[researchindustry]

Global Induced Pluripotent Market Growth, Trends and Absolute Opportunity up to 2026

Global induced pluripotent market is expected to rise to an estimated value of USD 2.33 billion by 2026, registering a substantial CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing prevalence of chronic diseases and ailments requiring the development of modern technologically advanced therapeutic options.

Key Market Competitors: Global Induced Pluripotent Market

Few of the major competitors currently working in the induced pluripotent market are Bristol-Myers Squibb Company; CELGENE CORPORATION; Astellas Pharma Inc.; Thermo Fisher Scientific; Cell Applications, Inc.; Axol Bioscience Ltd.; Organogenesis Holdings; Merck KGaA; FUJIFILM Holdings Corporation; Fate Therapeutics; KCI Licensing, Inc.; Japan Tissue Engineering Co., Ltd.; Vericel; ViaCyte, Inc.; STEMCELL Technologies Inc.; Horizon Discovery Group plc; Lonza; Takara Bio Inc.; Promega Corporation and QIAGEN.

Download PDF Sample report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-induced-pluripotent-market

Induced pluripotent are a specialized form of stem cells that are extracted from either skin or blood cells, and are then modified into the pluripotent form which gives them the capability of being used for the treatment where any different kind of human cells are required. In the pluripotent form, they can be modified to any kind of cell form that is utilized for the treatment of different diseases/disorders.

Competitive Analysis: Global Induced Pluripotent Market

Global induced pluripotent market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of induced pluripotent market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Market Segmentation: Global Induced Pluripotent Market

·         By Product Category (Cell Culture, Differentiation, Reprogramming, Engineering, Cell Analysis, Others)

·         By Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Neurons, Others)

·         By Application (Drug Development, Regenerative Medicine, Toxicity Testing, Academic Research, Stem Cell Bio-Banking)

·         By End-User (Academic & Research Institutes, Biotechnology Companies, Hospitals)

·         By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)

Speak to Analyst @ https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-induced-pluripotent-market

Market Drivers

·         Rise in the expenditure incurred by various private and government sources on R&D is expected to drive the growth of the market

·         High levels of understanding and awareness regarding the composition of the iPSC (Induced Pluripotent Stem Cell) has resulted in a rise of demand of the product from various end-users; this factor is expected to drive the growth of the market

·         Utilization of these cells for the creation of customized tissues and helping in understanding of human development; this factor is expected to drive the growth of the market

Market Restraints

·         Complications and large costs associated with the development and manufacturing of these products are expected to restrain the growth of the market

·         Chances of health risks due to the acceptance of these products in the recipient’s body along with lack of efficiency in the process are factors restraining the growth of the market

Reasons to Purchase this Report

·         Current and future of global induced pluripotent market outlook in the developed and emerging markets

·         The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

·         Regions/Countries that are expected to witness the fastest growth rates during the forecast period

·         The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

·         All segmentation provided above in this report is represented at country level

·         All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Browse full report @ https://www.databridgemarketresearch.com/reports/global-induced-pluripotent-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

 Related Reports:

 Global Chronic Idiopathic Constipation Treatment Market

 Global Diabetic Gastroparesis Treatment Market

[karishmamulani]

Induced Pluripotent Stem Cell (iPSC) Market 2021 Global Trends, Growth, Opportunities and Market Forecast To 2028

Induced Pluripotent Stem Cell (iPSC) Market 2021 Global Trends, Growth, Opportunities and Market Forecast To 2028

The global Induced Pluripotent Stem Cell (iPSC) market size is expected to reach USD 2,893.3 million by 2028 according to a new study by Polaris Market Research. The report “iPSC Market Share, Size, Trends, Industry Analysis Report By Application (Manufacturing, Academic Research, Drug Development & Discovery, Toxicity Screening, Regenerative Medicine); By Derived Cell; By Region, Segment &…